Canada · Health Canada Drug Product Database

TRIAMINIC EXPECTORANT DH SYRUP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
15203
DIN
01906615
Form
Syrup
Company as listed by source
NOVARTIS CONSUMER HEALTH CANADA INC.
Source status
Cancelled Post Market (2001-04-06)
Source last updated
2025-03-22

Source-listed ingredients

  • PHENYLPROPANOLAMINE HYDROCHLORIDE — 12.5 MG — per 5 ML
  • PHENIRAMINE MALEATE — 6.25 MG — per 5 ML
  • PYRILAMINE MALEATE — 6.25 MG — per 5 ML
  • GUAIFENESIN — 100 MG — per 5 ML
  • HYDROCODONE BITARTRATE — 1.67 MG — per 5 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 500ml

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →